Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor a transgenes

Cancer Research

Volumn 56, Issue 9, 1996, Pages 2137-2142

  Sargent, Linda M ^a   Sanderson, Nancy D ^a   Thorgeirsson, Snorri S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; DYSPLASIA; GENE MUTATION; GENE TARGETING; GENETIC SUSCEPTIBILITY; KARYOTYPE; LIVER CARCINOGENESIS; NONHUMAN; ONCOGENE C MYC; PLOIDY; PRIORITY JOURNAL; RAT; TRANSGENE; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL DIVISION; CHROMOSOME BANDING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; GENES, MYC; HUMANS; KARYOTYPING; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; PLOIDIES; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0029926712     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Yeh, S-H , Chen, P-J , Lai, M-Y., Wang, C-C., and Chen, D-S. Frequent genetic alterations at the distal region of chromosome Ip in human hepatocellular carcinomas. Cancer Res , 54: 4188-4192, 1994.
2. Wang, H. P., and Rogler, C. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet. Cell Genet., 48: 72-78, 1988.
3. Buetow, K. H., Murray, J. C., Israel, J. L., London, W. T., Smith, M , Kew, M., Blanquet, V , Brechot, C., Redeker, A., and Govindarajah, S Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Genetics, 86: 8852-8856, 1989.
4. Tsuda, H., Zhang, W. and Shimasato, Y. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 87. 6791-6794, 1990.
5. Emi, M., Fujiwara, Y., Nakajima, T , Tsuchiya, E., Tsuda, H., Hirohashi, S., Maeda, Y., Tsuruta, K., Miyaki, M., and Nakamura, Y. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer and lung cancer. Cancer Res., 52. 5368-5372, 1992.
6. Zhang, W , Hirohashi, S., Tsuda, H., Shimasato, Y., Yokata, J., Terada, M , and Sugimura, T Frequent loss of heterozygosity on chromosome 16 and 4 in human hepatocellular carcinoma. Jpn. J. Cancer Res., 81: 108-111, 1990.
7. Fujimori, M., Tokino, T., Hino, O , Kitagawa, T., Imamura, T., Okamoto, E., Mitsunobu, M., Ishikawa, T., Nakagama, H , Harada, H , Yagura, M., Matsubara, K., and Nakamura, Y Allelotype of study of primary hepatocellular carcinoma Cancer Res., 51: 89-93, 1991.
8. Simon, D , Knowles, B. B , and Weith, A. Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas Oncogene, 6: 765-770, 1991.
9. Walker, G. J., Hayward, N. K., Falvery, S., and Cooksley, W. G. E Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res., 51: 4367-4370, 1991
10. Fujimoto, Y , Hampton, L. L., Wirth, P. J , Wang, N. J., Xie, J. P., and Thorgeirsson, S. S Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res., 54. 281-285, 1994.
11. Aldaz, M C., Gollahon, L. S , and Chen, A. Systematic H-ras amplification in ovary-independent mammary tumors: correlation with progressively anaplastic phenotypes Cancer Res., 53: 5339-5344, 1993
12. Yunis, J. J., and Soreng, A. L. Constitutive fragile sites and cancer. Science (Washington DC), 226: 1199-1204, 1984.
13. Le Beau, M M. Chromosomal fragile sites and cancer-specific breakpoints - a moderating viewpoint Cancer Genet. Cytogenet, 31: 55-60, 1988.
14. Elder, F. B., and Robinson, F. B. Rodent common fragile sues: are they conserved? Evidence from mouse and rat. Chromosoma, 97: 459-464, 1989.
15. Yunis, J J. Multiple recurrent genomic rearrangements and fragile sites in human cancer. Somat. Cell. Mol. Genet., 13 397-403, 1987.
16. Searle, A. G., Peter, J . Lyon, M. F., Evans, E. P., Edwards, J H., and Buckle, V J. Chromosome maps of man and mouse. III. Genomics, 1: 3-18, 1987
17. Copeland, N. G , Jenkins, N A , Gilbert, D J., and Eppig, J. T. A genetic linkage map of the mouse, current applications and future prospects. Science (Washington DC), 262: 57-66, 1993.
18. Garibaldi, M., Manenti, G., Canaan, F., Falvella, F. S , Pierotti, M. A., Porta, G. D., Binelli, G , and Dragani, T. A. Chromosome mapping of murine susceptibility loci to liver carcinogenesis Cancer Res., 53: 209-211, 1993.
19. Lee, G-H., Bennett, M L., Carabao, R. A., and Drinkwater, N R. Identification of hepatocarcinogen-resistance genes in DBA/2 mice. Genetics, 139: 387-395, 1995.
20. Bennett, M. L , and Drinkwater, N R. Localization of the Htm gene to the distal region of mouse chromosome one Proc Am. Assoc. Cancer Res., 34: 144, 1993.
21. Derynck, R., Goeddel, D U , Ullrich, A , Gutterman, J. U., Williams, R. D., Bringman, T. S , and Berger, W. H Synthesis of mRNAs for transforming growth factor α and β and the epidermal growth factor receptor by human tumors. Cancer Res., 47: 707-712, 1987.
22. Sandgren, E P., Quaife, C J., Pinkert, C A , Palmiter, R D., and Brinster, R. L. Oncogene-induced liver neoplasia in transgenic mice. Oncogene, 4. 715-724, 1989.
23. Jhappan, C , Stahle, C., Harkins, R N., Fausto. N., Smith, G H., and Merlino, G. T TGF-α overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas Cell, 61: 1137-1146, 1990.
24. Sandgren, E P , Luetteke, N. C , Qiu, T. H., Palmiter, R. D., Brinster, R. L., and Lee, D C. Transforming growth factor a dramatically enhances oncogene induced carcinogenesis in transgenic mouse pancreas and liver. Mol. Cell Biol., 13: 320-330, 1993.
25. Murakami, H., Sanderson, N , Nagy, P., Marino, P., Merlino, G T , and Thorgeirsson, S. S Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor a in hepatic oncogenesis Cancer Res., 53. 1719-1723, 1993.
26. Martin, I., Illett, K. J., and Ninchin, F Characterisation of putrescine uptake by cultured adult mouse hepatocytes Biochim. Biophys. Acta, 1051. 52-59, 1990.
27. Dragan, Y. P., Sargent, L., Xu, Y-H, and Pitot, H. C. The initiation-promotion-progression model of rat hepatocarcinogenesis. Proc. Soc. Exp. Biol Med., 202: 16-24, 1993.
28. Xu, Y-H , Sattler, G. L , and Pitot, H. C. A method for the comparative study of replicative DNA synthesis in GGT-positive and GGT-negative hepatocytes in primary culture isolated from carcinogen-treated rats. In Vitro, 24: 995-1000, 1988.
29. Sargent, L. M., Sattler, G. L., Roloff, B., Xu, Y-H, Sattler, C. A., Meisner, L., and Pitot, H. C Ploidy and specific karyotypic changes during promotion with pheno-barbital, 2,5,2′,5′-tetrachlorobiphenyl, and/or 3,4,3′,4′-tetrachlorobiphenyl in rat liver. Cancer Res., 52 955-962, 1992.
30. Cowell, J. K A photographic representation of the variability in the G-banded structure of the chromosomes in the mouse karyotype. Chromosoma, 89: 294-320, 1984
31. Paweletz, N., Ghosh, S , and Vig, B. K. Mitosis and the induction of aneuploidy. Prog Clin. Biol. Res , 318: 217-229, 1989
32. Brinkley, B. R , Tousson, A., and Valdivia, M M The kinetochore of mammalian chromosomes: structure and function in normal mitosis and aneuploidy Basic Life Sci., 36. 243-267, 1985.
33. Liang, J C , and Brinkley, B. R. Chemical probes as possible targets for the induction of aneuploidy. Basic Life Sci., 36: 491-505, 1985
34. Danielsen, H. E , Brogger, A., and Reith, A. Specific gain of chromosome 19 in preneoplastic mouse liver cells after diethylnitrosamine treatment. Carcinogenesis (Lond.), 12: 177-180, 1988
35. Becker, F. F., Fox, R. A., Klein, L M., and Wolman, S R. Chromosome patterns in rat hepatocytes during N-2-fluorenylacetamide carcinogenesis. J. Natl. Cancer Inst., 46: 1261-1269, 1971
36. Herens, C., Gonzalez, M. L., and Barbason, H. Cytogenetic changes in hepatomas from rats treated with chrome exposure to diethylnitrosamine. Cancer Genet. Cytogenet., 60: 45-52, 1992.
37. Cowell, J. K , and Wig&ey. C. B. Chromosome changes associated with the progression of cell lines from preneoplastic to tumorigenic phenotype during transformation of mouse salivary gland J Natl. Cancer Inst., 69. 425-433, 1982.
38. Aldaz, C. M., Conti, C. J., Klein-Szanto, A. J. P., and Slaga, T. J. Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: relevance to malignancy. Proc. Natl. Acad. Sci. USA. 84: 2029-2032, 1987.
39. Popescu, N. C. Chromosome fragility and instability in human cancer Crit. Rev Oncog., 5: 121-140, 1994.
40. Hecht, D F. Fragile sites, cancer chromosome breakpoints and oncogenes all cluster in light G bands. Cancer Genet. Cytogenet., 31. 17-20, 1988.
41. Glover, T. W., and Stein, C. K. Chromosome breakage and recombination at fragile sites Am. J Hum. Genet., 43: 265-273, 1988
42. Davis, L. M , Caspary, W. J , Sakallah, S. A., Maronpot, R., Wiseman, R., Barrett, J. C , Elliott, R., and Hozier, J. C. Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse. Carcinogenesis (Lond.), 15: 1637-1645, 1994.
43. Nishimori, H., Ogawa, K., and Tateno, H. Frequent deletion in chromosome 4 and duplication of chromosome 15 in liver epithelial cells derived from long term culture of C3H mouse hepatocytes. Im. J. Cancer. 59: 108-113, 1994
44. Miyasaka, EC, Ohtake, K., Nomura, K., Kanda, H., Kominami, R., Miyashita, N , and Kitagawa, T. Frequent loss of heterozygosity on chromosome 4 in diethylnitrosamine-induced C3H/MSM mouse hepatocellular carcinomas in culture. Mol. Carcinog., 13: 37-43, 1995
45. Genuardi, M., Tsihiara, H , Anderson, D. E., and Saunders, G. F. Distal deletion of chromosome 1p in ductal carcinoma of the breast. Am. J Hum. Genet., 45: 73-82, 1989.
46. Bieche, I., Champeme, M. H., Matifas, F , and Cropp, C. S. Two distinct regions involved in 1p deletion in human primary breast cancer Cancer Res , 53. 1990-1994, 1993.
47. Tanaka, K., Yanoshita, R., Konishi, M , and Oshimura, M Suppression of tumourigenicity in human colon carcinoma cells by introduction of normal chromosome 1p36 region. Oncogene, 8: 2253-2258, 1993.
48. Jonasson, J , Povey, S., and Harris, H. The analysis of malignancy by cell fusion VII Cytogenetic analysis of hybrids between malignant and diploid cells and of tumours derived from them. J. Cell Sci., 24. 217-254, 1977.
49. Nobori, T., Miura, K , Wu, D. J., Lois, A., Takabayashi, K., and Carson, D. A Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers Nature (Lond.), 368: 753-756, 1994.
50. Nishida, N , Fukuda, Y., Komeda, T., Kita, R., Sando, T., Motonobu, F., Amenomori, M., Shibagaki, I., Nakao, K , Ikenaga, M., and Ishizaki, K. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma Cancer Res., 54. 3107-3110, 1994.
51. Byrne, J. A., and South, P. J. The 11p15.5 ribonucleotide reductase M1 subunit locus is not imprinted in Wilms' tumor and hepatoblastoma. Human Genet., 91: 275-277, 1993.
52. Albrecht, S., von Schweinitz, D., Waha, A , Kraus, J. A., Vondeimling, A., and Pietsch, T. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma Cancer Res., 54: 5041-5044, 1994.
53. Weiseman, R. W., Stowere, S J., Miller, E. C., Anderson, M. W., and Miller, J. A Activation of the mutations of the c-H-ras protooncogene in chemically induced hepatomas of the male B6C3F1 mouse. Proc. Natl Acad. Sci USA, 83: 5825-5829, 1986.
54. Reynolds, S H., Stowers, S. J , Patterson, R. M., and Maronpot, R. R. Activated oncogenes in B6C3F1 mouse liver tumors, implications for risk assessment. Science (Washington DC), 237: 1309-1316, 1987.
55. Lee, G. H Detection of activated c-H-ras oncogene in hepatocellular carcinomas developing in transgenic mice harboring albumin promoter-regulated simian virus 40 gene. Carcinogenesis (Lond ), 11: 1145-1148, 1990
56. Bremner, R., and Balmain, A. Genetic changes in skin tumor progression correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell, 61: 407-417, 1990
57. Held, W. A., Pazik, J., Giancola, J , O'Brien, G , Kerns, K., Gobey, M., Mels, R , Kenny, L., and Rustum, Y Genetic analysis of liver tumorigenesis in SV40 T antigen transgenic mice implies a role for imprinted genes. Cancer Res., 54: 6489-6495, 1994.
58. Weissman, B. E., Saxon, P. J., Pasquale, S. R., Jones, G. R., Geiser, A. G., and Standbridge, E J Introduction of a normal human chromosome 11 into Wilms' tumor cell line controls its tumorigenic expression. Science (Washington DC), 236: 175-180, 1987.
59. Davis, L. M , Caspary, W. J., Sakallah, S E , Maronpot, R., Wiseman, R., Barrett J. C , Elliott, R., and Hozier, J. C , Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse Carcinogenesis (Lond.), 15. 1637-1645, 1994